48,830
edits
Line 9: | Line 9: | ||
| LMDDx = [[lymphoma]], [[urothelial carcinoma]] and inflammation, metastatic [[lymphoepithelioma-like carcinoma]] | | LMDDx = [[lymphoma]], [[urothelial carcinoma]] and inflammation, metastatic [[lymphoepithelioma-like carcinoma]] | ||
| Stains = | | Stains = | ||
| IHC = | | IHC = CK34betaE12 +ve, p63 +ve/-ve, CK7 +ve/-ve, CK20 -ve, CD30 -ve | ||
| EM = | | EM = | ||
| Molecular = | | Molecular = | ||
Line 64: | Line 64: | ||
==IHC== | ==IHC== | ||
Features:<ref name=pmid21383609/> | Features:<ref name=pmid21383609/> | ||
*p53 +ve/-ve. | *p53 +ve/-ve. (+ve in ~60% of cases). | ||
*CK34betaE12 +ve (+ve in ~75% of cases). | |||
*CK7 +ve/-ve (+ve in ~60% of cases). | |||
*p63 +ve/-ve (+ve in ~50% of cases). | |||
Others:<ref name=pmid21383609/> | |||
*CK20 -ve. | *CK20 -ve. | ||
*TTF-1 -ve. | *TTF-1 -ve. | ||
*CD30 -ve. | *CD30 -ve. | ||
==See also== | ==See also== |
edits